Global $3.28 Billion Probiotic Supplements Market (2018-2027): Development of Dry Probiotic Supplements for Chronic Diseases will Fuel Growth at an Expected CAGR of 10.15% During 2018-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Probiotic Supplements Market (2018-2027)” report has been
added to ResearchAndMarkets.com’s offering.

The global probiotic supplements market is projected to expand at a
compound annual growth rate (CAGR) of 10.43% and will reach USD 3.28 Bn
by 2027. Awareness about health and fitness is augmenting the need for
nutritional diets and maintenance of healthy microbiota, thereby
propelling the demand for probiotic supplements.

Form Segment Insights

Probiotics are consumed mostly in dry form as capsules, powder,
chewable, and tablets. The rising adoption of gummies and chewable
probiotic supplements is expected to increase the growth of the dry
probiotics market across the world. The dry probiotic supplements
segment held a market share of 83% in 2017. The development of dry
probiotic supplements for chronic diseases will fuel the growth of the
segment, at an expected CAGR of 10.15% during the 2018-2027 period.

Source Segment Insights

Based on the source, the market was dominated by the bacteria-based
probiotic supplements segment, with a 91% share in 2017. Most probiotic
supplements include bacterial strains, of which, Lactobacillus sp and
Bifidobacterium sp are used widely for the maintenance of healthy
microbiota.

Distribution Channel Segment Insights

The pharmacy store-based probiotic supplements segment was the leading
contributor to the global probiotic supplements market, having generated
46% of the market value in 2017. However, the online store-based
probiotic supplements segment is expected to witness the highest
expansion, at a CAGR of 13.49% during the 2018-2027 period. The key
online distribution channels for probiotic supplements include Amazon,
Costco, and The Vitamin Shoppe, among others.

Application Segmentation Insights

The segment for gastrointestinal health will be the leading contributor
to the global probiotic supplements market and is anticipated to
contribute approximately 64% to the global market value by 2027. The
reason for being the leading application segment can be attributed to
the increasing prevalence of digestive diseases and diarrhea, due to
changing food habits and lifestyle, especially in developing countries.

Regional Insights

The North America probiotic supplements market is projected to expand at
a CAGR of 10.68% during the 2018-2027 period, leading to global revenue
of USD 1483.1 Mn by 2027. Increasing awareness about the benefits of
probiotic supplements and inclinations towards preventive care will aid
the growth of the market. The Asia-Pacific probiotic supplements market
is expected to expand at the highest CAGR of 11.34% between 2018 and
2027.

Key Topics Covered

Chapter 1: Executive summary

1.1. Market scope and segmentation

1.2. Key questions answered in this study

1.3. Executive summary – I

1.4. Executive summary – II

Chapter 2: Global probiotic supplements market – overview

2.1. Global market overview – market trends, market attractiveness
analysis, geography-wise market revenue (USD Mn)

2.2. Global market drivers and challenges

2.3. Value chain analysis

2.4. Porter’s five forces analysis

2.5. Strategic imperatives for success and growth

2.6. Market size – based on source (bacteria and yeast)

2.6. a. Bacteria – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

2.6. b. Yeast – historical (2017) and forecasted (2018-2027) market size
(USD Mn), and key market observations

2.7. Market size – based on form (liquid, dry [capsules, chewable,
tablets, powder, and others])

2.7. a. Liquid – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

2.7. b. Dry – historical (2017) and forecasted (2018-2027) market size
(USD Mn), and key market observations

2.7. b.i. Capsules – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

2.7. b.ii. Chewable – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.7. b.iii. Tablets – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.7. b.iv. Powder – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

2.7. b. v. Others – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

2.8. Market size – based on distribution channel (pharmacy,
hypermarkets/supermarkets, online sales, specialty stores, and direct
sales)

2.8. a. Pharmacy – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

2.8. b. Hypermarkets/supermarkets – historical (2017) and forecasted
(2018-2027) market size (USD Mn), and key market observations

2.8. c. Online sales – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.8. d. Specialty stores – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.8. e. Direct sales – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.9. Market size – based on application (gastrointestinal health, immune
health, vaginal health, urinary tract health, oral health, and others)

2.9. a. Gastrointestinal health – historical (2017) and forecasted
(2018-2027) market size (USD Mn), and key market observations

2.9. b. Immune health – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.9. c. Vaginal health – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.9. d. Urinary tract health – historical (2017) and forecasted
(2018-2027) market size (USD Mn), and key market observations

2.9. e. Oral health – historical (2017) and forecasted (2018-2027)
market size (USD Mn), and key market observations

2.9. f. Others – historical (2017) and forecasted (2018-2027) market
size (USD Mn), and key market observations

Chapter 3: North America probiotic supplements market – overview

Chapter 4: Europe probiotic supplements market – overview

Chapter 5: Asia-Pacific probiotic supplements market – overview

Chapter 6: Latin America probiotic supplements market – overview

Chapter 7: The Middle East and Africa probiotic supplements
market – overview

Chapter 8: Competitive landscape

8.1. Market share of key companies

8.2. Sanofi

8.1.a. Company snapshot

8.1.b. Product offerings

8.1.c. Strategic initiatives

8.1.d. Geographical presence

8.1.e. Key numbers

8.3. The Procter & Gamble Company

8.4. Novartis

8.5. i-Health Inc.

8.6. Taisho Pharmaceutical Holdings Co. Ltd.

8.7. BioGaia

8.8. Bayer Group

8.9. Probi AB

8.10. RENEW LIFE

8.11. Danisco A/S

Chapter 9: Conclusion

Chapter 10: Appendix

10.1. List of tables

10.2. Research methodology

10.3. Assumptions

For more information about this report visit https://www.researchandmarkets.com/r/laoo6f

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Health
Food and Sports Nutrition